- Exchange: Frankfurt
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Galena Biopharma Inc+ Add to Watchlist
RXK:GR2.877 EUR 0.027 0.95%
As of 02:05:29 ET on 12/20/2013.
Company Profile for Galena Biopharma Inc (RXK)
Galena Biopharma, Inc. is a biopharmaceuticals company that develops late-stage oncology drugs. The Company develops therapies that activate cells in the immune system to seek out and eliminate tumor cells without harming healthy tissue.
Galena Biopharma Inc
Key Executives for Galena Biopharma Inc (RXK)
|Mark J AhnPresident/CEO||Mark W SchwartzExec VP/COO|
|Rosemary MazanetExec VP/Chief Medical Officer||Remy BernardaVP:Marketing & Communications|
|Ryan M DunlapDir:Finance/Secy/Controller|